Nancy Thomas, PA
Surgical · Beaufort, SCNPI 1972906626
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. Teleflex LLC accounts for 64.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $1,855 and has fallen 87.2% since, to $237 in 2025.
Across 54 payments — averaging $50.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$2K
- Agiliti Surgical, Inc.$237
- Boston Scientific$164
- Astellas Pharma US Inc$133
- Sumitomo Pharma America, Inc.$82
- Bayer$62
- plus $296 from 13 others
What the payments were for
- Travel & lodging$1,28647%
- Food & beverage$1,33849%
- Education$893%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 20 | $1,740 |
| Agiliti Surgical, Inc. | 1 | $237 |
| Boston Scientific | 3 | $164 |
| Astellas Pharma US Inc | 5 | $133 |
| Sumitomo Pharma America, Inc. | 4 | $82 |
| Bayer | 4 | $62 |
| Myovant Sciences Inc. | 3 | $60 |
| Urovant Sciences Inc | 2 | $33 |
| AbbVie | 2 | $30 |
| Axonics, Inc. | 1 | $22 |
| Procept Biorobotics Corporation | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Progenics Pharmaceuticals, Inc. | 1 | $18 |
| Accord Healthcare, Inc. | 1 | $18 |
| Ambu Inc. | 1 | $17 |
| Tolmar, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
| Hollister Incorporated | 1 | $13 |
| Sagent Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift System$1,271
- Sonablate HIFU$237
- Koelis Trinity MRI/US Fusion$237
- rezum Generator$123
How this compares
$2,713 in reported general payments places this provider in the 85th percentile of 232 surgical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 309 | $207,983 |
| GemtesaVibegron | 136 | $105,521 |
| Dutasteride | 430 | $18,591 |
| Mirabegron ErMirabegron | 25 | $12,504 |
| Tamsulosin Hcl | 449 | $7,313 |
| Tadalafil | 81 | $4,568 |
| Potassium Citrate ErPotassium Citrate | 43 | $4,339 |
| Solifenacin Succinate | 65 | $3,858 |
| Estradiol | 50 | $3,693 |
| Silodosin | 30 | $3,232 |
| Finasteride | 159 | $2,938 |
| Methenamine Hippurate | 56 | $2,735 |
| RenacidinCitric Ac/Gluconolact/Mag Carb | 11 | $1,968 |
| Testosterone | 20 | $1,505 |
| Bicalutamide | 48 | $1,061 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $133 | $207,983309 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $82 | $105,521136 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 232 surgical providers in South Carolina.
Other surgical in Beaufort
- Joshua BeardsleyRock Hill$192K
- Carey LennonNorth Charleston$22K
- Bryce StallingsColumbia$16K
- Natalie StapletonGreenville$11K
- Kevin KnappGreenville$11K
- Jeffrey BrownSpartanburg$7K
- Kati CarterGreenville$7K
- Kalley VeitCharleston$7K
- Brett HarmanNorth Charleston$7K
- Christopher ButhornCharleston$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.